Effective April 12, 2023, Dr. Rushing will lead innovative research efforts for Okur-Chung Neurodevelopmental Syndrome, an ultra-rare genetic condition. In an exciting new development, CSNK2A1 Foundation, a patient-centered 501(c)(3) nonprofit organization dedicated to advancing the understanding and treatment of Okur-Chung Neurodevelopmental Syndrome (“OCNDS”), announced the appointment of Dr. Gabrielle Rushing as their new Science Program […]
